Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sharps Compliance (SMED)

Sharps Compliance (SMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sharps Compliance 9220 KIRBY DRIVE STE 500 HOUSTON TX 77054 USA

P: 713-432-0300 F: 713-838-0508

Description:

Headquartered in Houston, Texas, SHARPS COMPLIANCE is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste. The Company's flagship product, the Sharps Disposal by Mail System, is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin. The Company also offers a number of products specifically designed for the home healthcare market. Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, healthcare, commercial, professional and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting.

Key Statistics

Overview:

Market Capitalization, $K 170,013
Enterprise Value, $K 146,313
Shares Outstanding, K 19,430
Annual Sales, $ 76,420 K
Annual Net Income, $ 12,870 K
Last Quarter Sales, $ 17,580 K
Last Quarter Net Income, $ -290 K
60-Month Beta 1.27
% of Insider Shareholders 4.80%
% of Institutional Shareholders 56.06%
Float, K 18,497
% Float 95.20%
Short Volume Ratio 0.35

Growth:

1-Year Return -1.24%
3-Year Return 127.27%
5-Year Return 76.77%
5-Year Revenue Growth 128.94%
5-Year Earnings Growth 6,200.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 05/11/22
Next Earnings Date 08/24/22
Earnings Per Share ttm 0.19
EPS Growth vs. Prev Qtr -114.29%
EPS Growth vs. Prev Year -102.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SMED Ratios

Ratio
Price/Earnings ttm 46.00
Price/Earnings forward 105.00
Price/Earnings to Growth N/A
Return-on-Equity % 5.48%
Return-on-Assets % 3.71%
Profit Margin % 16.84
Net Margin % -15.34
Debt/Equity 0.06
Price/Sales 2.33
Price/Cash Flow 11.86
Price/Book 2.61
Book Value/Share 3.35
Interest Coverage 76.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar